Related Experiment Video
Updated: Aug 5, 2026
08:17
VIGS-Mediated Forward Genetics Screening for Identification of Genes Involved in Nonhost Resistance
Published on: August 23, 2013
Quest for antimicrobial genes to engineer disease-resistant crops
1Aventis CropScience, Jozef Plateaustraat 22, B-9000 Gent, Belgium. erik.vanderbiezen@aventis.com
Trends in Plant Science
|March 10, 2001
Summary
Antimicrobial peptides, natural defense molecules, are being used to genetically engineer crops for disease resistance. This approach promises enhanced crop protection and more sustainable agriculture.
Area of Science:
- Biochemistry
- Plant Science
- Immunology
Background:
- Antimicrobial peptides (AMPs) are vital components of the innate immune system across all life forms.
- These peptides possess inherent antimicrobial properties, offering a natural defense mechanism.
Purpose of the Study:
- To explore the potential of antimicrobial peptides in developing disease-resistant crop plants.
- To assess the contribution of AMPs to sustainable agricultural practices through genetic engineering.
Main Methods:
- Genetic engineering of crop plants to express specific antimicrobial peptides.
- Evaluation of the efficacy of engineered plants in controlling agricultural diseases.
Main Results:
- Antimicrobial peptides show promise for conferring disease resistance in crops.
- Specific combinations of potent antimicrobial peptides are expected to yield significant disease control.
Conclusions:
- Genetically engineered disease-resistant crops utilizing antimicrobial peptides are a viable strategy.
- This technology is anticipated to advance sustainable agriculture by reducing crop losses and reliance on chemical treatments.
More Related Videos
Related Concept Videos
00:57Antibiotic Selection
Overview
01:59Plant Breeding and Biotechnology
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
02:50Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
01:28Gene Regulation in Microbial Communities: Quorum Sensing
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...